Live Breaking News & Updates on Prnewswire Genprex Inc|Page 3

Stay updated with breaking news from Prnewswire genprex inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genprex Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Genprex Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Kalyn Dabbs , Securities Exchange , Drug Administration , Exchange Commission , Prnewswire Genprex Inc , Genprex Inc , Hc Wainwright Co , File Number , Nanoparticle Delivery System , Fast Track Designation , Looking Statements , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Current Reports ,

Genprex Publishes Positive Clinical Data from Phase 1 Portion of Acclaim-1 Clinical Trial Evaluating REQORSA® Immunogene Therapy in Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies. ....

United States , Rodney Varner , Mark Berger , American Society Of Clinical Oncology , Genprex Inc , Prnewswire Genprex Inc , Company Website , Exchange Commission , Drug Administration , Results Show Combination , Well Tolerated , All Three Dose Levels , Encouraging Evidence , Immunogene Therapy , Clinical Oncology , Annual Meeting , Chief Medical Officer , Publication Only , Developmental Therapeutics , Molecularly Targeted Agents , Chief Executve Officer , Nanoparticle Delivery System , Fast Track Designation , Private Securities Litigation Reform Act , Annual Report ,

Genprex Publishes Positive Clinical Data from Phase 1 Portion of Acclaim-1 Clinical Trial Evaluating REQORSA® Immunogene Therapy in Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting

Genprex Publishes Positive Clinical Data from Phase 1 Portion of Acclaim-1 Clinical Trial Evaluating REQORSA® Immunogene Therapy in Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Kalyn Dabbs , Rodney Varner , Mark Berger , American Society Of Clinical Oncology , Drug Administration , Prnewswire Genprex Inc , Exchange Commission , Company Website , Genprex Inc , Results Show Combination , Well Tolerated , All Three Dose Levels , Encouraging Evidence , Immunogene Therapy , Clinical Oncology , Annual Meeting , Chief Medical Officer , Publication Only , Developmental Therapeutics , Molecularly Targeted Agents , Chief Executve Officer , Nanoparticle Delivery System , Fast Track Designation , Private Securities Litigation Reform Act , Annual Report ,

Independent Researchers Find That TUSC2, the Gene Delivered by Genprex's REQORSA®, Functions as a Novel Tumor Suppressor for Glioblastoma

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies. ....

United States , Rodney Varner , National Brain Tumor Society , Drug Administration , Genprex Inc , Exchange Commission , Prnewswire Genprex Inc , Pre Clinical Study , Cancer Research Annual Meeting , Chief Executive Officer , Nanoparticle Delivery System , Fast Track Designation , Private Securities Litigation Reform Act , Annual Report ,

Genprex to Participate in March Investor and Industry Conferences

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies. ....

Laguna Niguel , United States , Dana Point , Rodney Varner , Messe Basel , Senior Leadership Team , Genprex Inc , Drug Administration , Prnewswire Genprex Inc , Company To Showcase , Exchange Commission , Innovate Gene Therapy Programs , Annual Roth , Roth Conference , Chief Financial Officer , Europe Spring , Chief Executive Officer , Nanoparticle Delivery System , Fast Track Designation , Private Securities Litigation Reform Act , Annual Report ,